Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2001
10/02/2001CA2191222C Dna encoding the bacillus licheniformis pwd-1 keratinase
10/02/2001CA2148223C Bacteriocins from streptococcus thermophilus
10/02/2001CA2020668C Fused or hybrid protein comprising viral antigen and lymphokine
10/02/2001CA1341299C Mammalian interleukin-4
09/2001
09/30/2001CA2341971A1 Method for quantifying dna binding activity of dna binding proteins
09/30/2001CA2340461A1 Hirulog-like peptide and gene therapy
09/27/2001WO2001071732A2 Porous ferro- or ferrimagnetic glass particles for isolating molecules
09/27/2001WO2001071358A1 Method of screening for inhibitors of osteopontin
09/27/2001WO2001071356A2 Peptide sequences comprising one or several protein binding units of the ena/vasp family, and uses thereof
09/27/2001WO2001071346A2 Binding compounds for cc chemokine receptor 5 and methods for identifying them
09/27/2001WO2001071044A1 Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
09/27/2001WO2001071043A1 Loop probe hybridization assay for polynucleotide analysis
09/27/2001WO2001071041A2 Microarray-based analysis of polynucleotide sequence variations
09/27/2001WO2001071040A2 Method for determination of gene function
09/27/2001WO2001071039A2 Combined polynucleotide sequences as discrete assay endpoints
09/27/2001WO2001071038A1 Inhibition of penicillin resistance in s. pneumoniae
09/27/2001WO2001071037A1 Methods of detecting polynucleotide kinase and its use as a label
09/27/2001WO2001071036A2 Methods of preparing amplified nucleic acid molecules
09/27/2001WO2001071032A1 Method of detecting risk factor for the onset of arteriosclerosis
09/27/2001WO2001071031A2 Carrier for gene detection and its use for detecting validity of interferon therapy
09/27/2001WO2001071029A1 Diagnosis of a person's risk of developing alcoholism
09/27/2001WO2001071027A2 mRNA AMPLIFICATION
09/27/2001WO2001071022A2 Lpa receptor agonists and antagonists and methods of use
09/27/2001WO2001071021A1 Process for producing l-amino acid via fermentation method
09/27/2001WO2001071019A1 Method of generating transgenic organisms using transposons
09/27/2001WO2001071018A2 Secreting products from skin by adeno-associated virus (aav) gene transfer
09/27/2001WO2001071017A2 Modified nodavirus rna for gene delivery
09/27/2001WO2001071015A2 Non-squamous epithelium-specific transcription
09/27/2001WO2001071014A2 Expression of recombinant human acetylcholinesterase in transgenic plants
09/27/2001WO2001071013A2 Melon promoters for expression of transgenes in plants
09/27/2001WO2001071012A1 Process for the fermentative preparation of l-amino acids with amplification of the gnd gene
09/27/2001WO2001071011A1 Vectors for the genetic transformation of lactobacillus sakei
09/27/2001WO2001071009A2 Whole-body optical imaging of gene expression and uses thereof
09/27/2001WO2001071008A1 Antisense inhibition of adam10 expression
09/27/2001WO2001071007A2 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF
09/27/2001WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
09/27/2001WO2001071004A2 Proteases
09/27/2001WO2001071003A1 A novel polypeptide, a human serine protease 8 and the polynucleotide encoding the polypeptide
09/27/2001WO2001071002A1 A novel polypeptide, a human ubiquitin carboxylic acid terminal hydrolase 11 and the polynucleotide encoding the polypeptide
09/27/2001WO2001071001A1 A novel polypeptide, a human tyrosinase 15 and the polynucleotide encoding the polypeptide
09/27/2001WO2001071000A1 Novel polypeptide--- a znt-1-22 and polynucleotide encoding it
09/27/2001WO2001070999A1 Novel polypeptide --- the amyloid precursor protein --- binding protein and polynucleotide encoding it
09/27/2001WO2001070998A1 Talaromyces emersonii beta-glucanases
09/27/2001WO2001070997A2 Regulation of human leucine aminopeptidase-like enzyme
09/27/2001WO2001070996A1 Method for desulfurization of dibenzothiophene using a recombinant pseudomonas putida strain as biocatalyst
09/27/2001WO2001070995A1 Process for the fermentative preparation of l-amino acids with amplification of the zwf gene
09/27/2001WO2001070994A1 A novel polypeptide, a human dihydropyridine dicarboxylic acid dehydrogenase 18 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070993A2 Polynucleotides that control delta-6-desaturase genes and methods for identifying compounds for modulating delta-6-desaturase
09/27/2001WO2001070992A1 Proteins and polypeptides from haemophilus influenza involved in paracytosis, nucleotide sequences encoding them and uses thereof
09/27/2001WO2001070991A1 Vaccine against mycobacterium infection based on epitopes of ag85 complex
09/27/2001WO2001070990A1 Nucleic acid sequences comprising at least a phage-resistance mechanism, plasmids containing same, lactic acid bacteria and use
09/27/2001WO2001070989A2 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins
09/27/2001WO2001070988A2 Receptors for hypersensitive response elicitors and uses thereof
09/27/2001WO2001070987A2 Novel inflorescence meristem development gene, promoter, and methods of use for same
09/27/2001WO2001070986A2 Helical protein zalpha51
09/27/2001WO2001070985A2 Bi-functional cancer treatment agents
09/27/2001WO2001070984A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
09/27/2001WO2001070983A1 A novel polypeptide, a human prostate specific membrane antibody proteine 9 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070982A2 Brca-1 regulators and methods of use
09/27/2001WO2001070981A2 Nucleic acids and polypeptides of invertebrate g-protein coupled receptors and methods of use
09/27/2001WO2001070980A2 Isolated g-protein coupled receptors, nucleic acid molecules encoding gpcr proteins, and uses thereof as insecticidal targets
09/27/2001WO2001070979A2 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
09/27/2001WO2001070978A2 Polypeptides and nucleic acids encoding same
09/27/2001WO2001070977A2 Fibroblast growth factor receptor-like molecules and uses thereof
09/27/2001WO2001070976A2 Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer
09/27/2001WO2001070975A1 Novel melanin concentrating hormone receptor
09/27/2001WO2001070974A1 Novel protein, process for producing the same and use thereof
09/27/2001WO2001070973A1 Precursors of silk-like materials, silk-like materials and processes for producing both
09/27/2001WO2001070972A2 Multiple human and mouse otoferlin isoforms
09/27/2001WO2001070971A2 Regulation of human mas oncogene-related g protein-coupled receptor
09/27/2001WO2001070970A2 Regulation of human opsin-related g protein-coupled receptor
09/27/2001WO2001070969A2 Regulation of human latrophilin-like g protein-coupled receptor
09/27/2001WO2001070968A2 Production of recombinant blood clotting factors in human cell lines
09/27/2001WO2001070967A2 Regulation of human serotonin-like g protein-coupled receptor
09/27/2001WO2001070966A1 A novel polypeptide, a human clathrin light chain 11 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070965A1 A novel polypeptide, a human regulatory transcription factor 15 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070964A1 A novel polypeptide, a human glucose transport like protein 18 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070963A1 A novel polypeptide, a human clotting factor ix-10 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070962A1 A novel polypeptide, a human plasminogen activator inhibitor 10 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070961A1 A novel polypeptide, a human microtubulin folding factor c16 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070960A1 A novel polypeptide, a human dna mismatch repair gene protein 13 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070959A1 A novel polypeptide, a human regulatory transcription factor 10 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070958A1 A novel polypeptide, a human dna mismatch repair protein 15 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070957A1 A novel polypeptide, a human dna mismatch repair protein 9.4 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070956A1 A novel polypeptide, a human dna mismatch repair protein 8 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070955A2 Identification of essential genes in prokaryotes
09/27/2001WO2001070954A2 Regulation of human nerve growth factor-elated g protein-coupled receptor
09/27/2001WO2001070953A2 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment
09/27/2001WO2001070952A1 Human gata-5 transcription factor
09/27/2001WO2001070951A2 Agent for the diagnosis and therapy of viral diseases
09/27/2001WO2001070950A2 Antisense nucleic acid molecules targeted to type i collagenase (mmp-1) for inhibition of melanoma invasion
09/27/2001WO2001070949A1 Genetic silencing
09/27/2001WO2001070948A2 Methods and compositions for elucidating protein expression profiles in cells
09/27/2001WO2001070947A2 Method for generating recombinant dna molecules in complex mixtures
09/27/2001WO2001070946A2 Methods for in vivo diversification of single genes
09/27/2001WO2001070945A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments
09/27/2001WO2001070944A2 Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene.
09/27/2001WO2001070943A2 Stable composition comprising a nuclease and a phosphatase
09/27/2001WO2001070942A2 Transformed plant having heterologous glucan branching enzyme activity
09/27/2001WO2001070941A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis